Full name: Mark Hwang
Current country: United States
Membership level: Full
Type of membership: Member
Number of publications: 26
Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis) Commencing Late in Life (2025)
https://pubmed.ncbi.nlm.nih.gov/39547689/
Associations of sociodemographic, clinical factors and HLA-B alleles with enthesitis and peripheral arthritis in patients with ankylosing spondylitis (2025)
https://pubmed.ncbi.nlm.nih.gov/40081912/
Psychometrics of inflammatory back pain criteria in the US population (2025)
https://pubmed.ncbi.nlm.nih.gov/41510560/
Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis (2025)
https://pubmed.ncbi.nlm.nih.gov/40676732/
Reliability and validity of the PROMIS-29 health profile in Ankylosing Spondylitis patients: A cross-sectional study (2024)
https://pubmed.ncbi.nlm.nih.gov/38428872/
Axial Imaging in Spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/39415369/
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis (2023)
https://pubmed.ncbi.nlm.nih.gov/37041650/
Biomechanics in the onset and severity of Spondyloarthritis; a force to be reckoned with. (2023)
https://pubmed.ncbi.nlm.nih.gov/37949613/
Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohort (2023)
https://pubmed.ncbi.nlm.nih.gov/37995469/
Does Gender Impact a Diagnosis of Ankylosing Spondylitis? (2022)
https://pubmed.ncbi.nlm.nih.gov/35352497/
Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis (2022)
https://pubmed.ncbi.nlm.nih.gov/36001102/
Health care utilization and costs associated with functional status in patients with psoriatic arthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/36001101/
Association between disability scores and opioid use in patients with psoriatic arthritis and ankylosing spondylitis (2022)
https://pubmed.ncbi.nlm.nih.gov/36469081/
Environmental Risks for Spondyloarthropathies (2022)
https://pubmed.ncbi.nlm.nih.gov/36332997/
Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study (2022)
https://pubmed.ncbi.nlm.nih.gov/36182115/
Identifying trajectories of radiographic spinal disease in ankylosing spondylitis: a 15-year follow-up study of the PSOAS cohor (2022)
https://pubmed.ncbi.nlm.nih.gov/34427579/
Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33128725/
The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial (2021)
https://pubmed.ncbi.nlm.nih.gov/32926247/
Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/34042330/
Ankylosing spondylitis risk factors: a systematic literature review (2021)
https://pubmed.ncbi.nlm.nih.gov/33754220/
The Need for SPACE to Plan the Future for Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34911807/
Associations of Depressive Symptoms in Ankylosing Spondylitis: Analysis from an Observational Cohort. (2020)
https://pubmed.ncbi.nlm.nih.gov/32166439/
Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study (2020)
https://pubmed.ncbi.nlm.nih.gov/32607793/
The changing profile of ankylosing spondylitis in the biologic era (2020)
https://pubmed.ncbi.nlm.nih.gov/32648102/
Measuring Outcomes in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33091248/
Reliability and Validity of Patient-Reported Outcomes Measurement Information System Short Forms in Ankylosing Spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/31371654/